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1. Introduction 
Matrix-bound nucleotides have recently attracted 
considerable interest mainly due to their excellent 
properties as adsorbents for affinity chromatography 
[l-5] . The application of immobilised nucleotides 
as active cofactors for dehydrogenases i another aspect 
that is also rapidly gaining momentum. Matrix-bound 
nicotinamide nucleotides could be repeatedly used and 
would thus be attractive components in enzyme reac- 
tors and enzyme electrodes. It has been shown that 
NAD’ coupled to agarose [6] or glass [7] is indeed 
active as a cofactor, but compared with free NAD’ the 
efficiency is rather limited, probably due to steric 
problems. Considerably more favourable results are 
likely to be achieved with soluble carriers as poly- 
ethyleneimine [S] and dextran which allow a more 
unhindered interaction between the cofactor and 
enzyme. 
The present report describes the preparation and 
characterisation of a soluble high molecular weight 
derivative of NAD’, dextran-NAD’, obtained by 
coupling NAD’-N6 - [N-(6-aminohexyl)-acetamide] 
to cyanogen bromide activated dextran, mol. wt. 
40 000. It is coenzymically active with yeast alcohol 
dehydrogenase (ADH) and rabbit muscle lactate dehy- 
drogenase (LDH) and can also recycle in a system con- 
taining both enzymes. 
2. Materials and methods 
Dextran T 40 (mol. wt. = 40 000) and Sepharose 
4B were obtained from PhaImacia Fine Chemicals 
(Uppsala, Sweden). Yeast alcohol dehydrogenase (335 
U/mg) and rabbit muscle lactate dehydrogenase (675 
U/mg) were purchased from Sigma (St. Louis, MO., 
U.S.A.). NAD’-N6-[N-(6-aminohexyl)-acetamide] was 
prepared essentially as described earlier [S] and the 
reduced analogue was obtained after reduction with 
yeast ADH [9]. Sepharose-NAD’ was prepared by 
coupling NAD’-N6 - [N-(6-aminohexyl)-acetamide] to 
cyanogen bromide activated Sepharose 4B [S,lO] . To 
minimise crosslinking of the gel, a rather low cyanogen 
bromide concentration (10 mg/g wet gel) was employed. 
The resulting Sepharose-NAD’ contained 25 pmoles 
nucleotide/g wet gel. Chemical reduction with sodium 
dithionite yielded Sepharose-NADH [5]. 
2.1. Preparation of dextran-NAD’ 
Dextran T 40 (5.0 g) was dissolved in 50 ml water 
(20°C), a solution of 0.25 g cyanogen bromide in 5 ml 
of water was added and pH maintained at 10.8 by 
continuous addition of 1 M NaOH. After 5 min the 
consumption of NaOH ceased and the activation was 
judged complete. The pH was lowered to 8.5 with 
0.1 M HCI and 0.90 mmol of NAD’-N6 - [N-(6-amino- 
hexyl)-acetamide] dissolved in 5 ml water was added. 
The coupling was allowed to proceed at pH 8.5 for 
12 hr at room temperature whence any residual active 
groups were quenched by treatment with 0.2 M 
ethanolamine-HCI buffer pH 8.0 for 1 hr at room 
temperature. The reaction mixture was diluted to 500 
ml with 0.1 M LiCI, adjusted to pH 6.8 with HCl and 
applied to a Sephadex G-50 column (85 X 5 cm). The 
dilution lowered the viscosity enough to prevent anoma- 
lous gel filtration behaviour. Elution was performed 
with 0.1 M LiCl and the effluent collected as 20 ml 
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fractions. Fractions 25-55 contained dextran-NAD’ 
and fractions 65-100 uncoupled analogue. The dextran 
derivative was concentrated on a rotary evaporator 
(30°C) to approximately 100 ml and then pipetted 
into 1.5 1 of vigorously stirred ethanol. The precipi- 
tate was filtered off, washed with ethanol and ether 
and dried in a vacuum yielding 5.1 g of a white powder. 
Ultraviolet measurements indicated a nucleotide con- 
tent of 65 ymoles/g and a coupling yield of 36% 
(assuming a molar absorption coefficient of 2 1 700 
M-’ cm-’ [5]). Th e same procedure was followed 
when ‘black dextran’ was prepared. In this case the 
NAD’ analogue was replaced by 0.90 mmol of n- 
butylamine. Chemical reduction with sodium dithionite 
gave dextran-NADH (11). The product contained 65 
pmoles/g according to measurements at 340 nm, assum- 
ing a molar absorption coefficient of 6200 M-’ cm-‘. 
2.2. Enzyme assays 
Cofactor reduction rates were determined with 
yeast ADH, cofactor oxidation rates with rabbit muscle 
LDH and cofactor cycling rates with both enzymes 
present in the assay medium. All determinations were 
carried out at 25°C and at pH 8.0 in an assay medium 
of the following composition: 100 mM ethanol, 10 
mM pyruvate, 1 mM glutathione, 50 mM Tris-HCl 
and 0.10 mM oxidised or reduced cofactor. In some 
assays 15.5 mg/ml of blank dextran was added (see 
table 1). 
The reduction and oxidation rates were calculated 
from direct spectrophotometric measurements at 340 
nm, and the reactions were initiated by adding 0.30 
pg/ml ADH or 0.06 pg/ml LDH. Assays with Sepharose- 
NAD(H) were carried out in a cell equipped with 
magnetic stirring to prevent settling of the gel, and to 
obtain reasonable conversion rates enzyme concentra- 
tions also higher than those given above were used 
(I-20 times). 
The cycling experiment was initiated by the addi- 
tion of 3.0 pg/ml ADH and 0.60 pg/ml LDH. At inter- 
vals, samples of 0.50 ml were withdrawn and pipetted 
into 0.50 ml of 0.25% Hz 02 and the mixture heated 
at 100°C for 20 min. The lactate concentrations were 
then determined enzymically by mixing the peroxide 
treated sample (0.050-0.200 ml) with 0.95-0.80 ml 
assay medium containing 100 pmoles glycine-NaOH 
buffer, pH 9.6, 200 pmoles hydrazine and 2.0 pmoles 
NAD’. LDH (50 pg) was added and after 2 hr the 
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change in absorbance at 340 nm was measured and the 
lactate concentration estimated by comparison with a 
standard curve. 
3. Results and discussion 
The NAD’ analogue NAD’- [N-(6-aminohexyl)- 
acetamide] was coupled via its terminal amino group 
to a soluble dextran giving dextran-NAD’ with a nucleo- 
tide content of 65 pmoles/g, which corresponds to 
about three cofactor molecules per dextran molecule. 
A procedure with a very low cyanogen bromide/dextran 
ratio (1 molecule of CN Br per 15 glucose residues) 
was adopted in order to minimise crosslinking of the 
polymer and also to ensure a medium practically devoid 
of unreacted cyanogen bromide when the NAD’ 
analogue was added. 
The ultraviolet spectrum of dextran-NAD’ in Tris 
buffer (fig. 1) had a maximum at 266 nm, characteristic 
of N6 substituted adenosine derivatives, and in 1 M 
KCN the spectrum showed an additional peak at 325 
nm, typical of N’ substituted nicotinamide. The ratio 
A325/A266 for dextran-NAD’ was calculated as 0.34 
and the same ratio for the free NAD’ analogue as 0.35, 
indicating that only neglible loss of nicotinamide had 
occurred during coupling. This was also supported by 
spectra obtained from dextran-NAD’ before and after 
reduction with dithionite. Reduction with yeast ADH 
at pH 9.5 also afforded the expected peak at 340 nm, 
and the amount of enzymically reducible nucleotide 
was calculated as approximately 80%. The remaining 
20% was probably sterically unavailable to the enzyme 
due to crosslinking of the polymer. The derivative was 
readily soluble in water, but yielded solutions more 
viscous than the original Dextran T 40 did, suggesting 
that some crosslinking actually had occurred during 
the activation and coupling steps. In line with this 
observation it was found that a 5-fold increase in 
cyanogen bromide concentration gave a very good 
coupling yield, but the derivative was difficult to 
dissolve in water and could be reduced enzymically 
only to the extent of 25%. The possibility that the 
coenzymically inactive portion consisted of analogues 
bound to dextran via some other group than the 
terminal aliphatic amino group is considered unlikely 
based on a separate experiment, where activated dextran 
was allowed to react with unsubstituted NAD’. Only 
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Fig. 1. Ultraviolet spectra of dextran-bound NAD* derivatives. 
The spectra were recorded on a Beckman Acta HI spectropho- 
tometer using a cell with a path length of 1.00 cm. The con- 
centration of dextran-NAD+ was 1.00 mg/ml. Spectrum in 
0.10 M Tris-HCl buffer, pH 7.5 (- 1. Spectrum in 1.0 
M KCN, t............. ). Spectrum obtained after reduction for 
15 min with yeast ADH (25 @g/ml) in 0.33 M ethanol and 
0.10 M glycine-NaOH buffer, pH 9.5 (- - s - - - -). The reference 
cells contained the same ingredients as the sample cefls except 
that dextran-NAD’ was replaced by blank dextran. 
0.0 
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Fig. 2. Recycling of free and polymer-bound nicotinamide 
nucleotides by the two-enzyme system alcohol dehydrogenase 
and lactate dehydrogenase. The cycling was monitored by 
determinations of lactate in samples withdrawn from the 
incubation mixtures. Details are given in Methods. 0 = NAD’. 
l = NAD’@- [N-(6-aminohexyl)-acetamide] . A= dextran- 
NAD+. A = Sepharose-NAD’. 
a very low coupling yield was however observed (1 
E.tmole/g). 
The dextr~-No+ preparation was stable when 
kept as a dry powder. No release of free nucleotide or 
loss of cofactor activity could be detected after three 
months torage at 4°C. The stability in aqueous media 
was also quite good, ~thou~ somewhat lower than 
would be expected of a derivative prepared by the 
cyanogen bromide coupling procedure [12 ] . After four 
days at 25°C in 0.1 M Tris-HCI buffer, pH 8.0, sepa- 
ration on a Sephadex G-50 column showed that 90% 
of the nucleotide remained attached to the dextran 
and was still reducible to an extent of 80% with yeast 
ADH. 
3.1. Cofactor activity 
The cofactor activity of native NAD’ with yeast 
ADH and rabbit muscle LDH was compared with that 
of the free analogue, NAD’-I@-[IV-(6.aminohexyl) 
acetamide] and the dextran- and Sepharose-bound 
analogues (fig. 2, table 1). As expected, NAD’ proved 
to be the most efficient cofactor in the systems tested. 
Substitution in position N6 reduced the activity to 
75-60%, attachment to dextran further decreased the 
activity to about 15% and binding to Sepharose, finally, 
yielded a derivative 2-3 orders of magnitude l ss effi- 
cient than NAD’. It is conceivable that the decreased 
coenzymic activity of the immobilised nucleotides i  
the result of s~elding by the polymer lattice and of 
restrictions imposed on the nucleotide mobilities. Thus, 
it is not surprising that 20% of dextran-bound nucleotide 
and about 70% of Sepharose-bound ucleotide could 
not be reduced at all by yeast ADH, even after ex- 
tended incubation with high enzyme concentrations. 
The dextran pofymer itself at the concentrations used 
seemed however not to affect the conversion rates to 
any appreciable extent. The table shows that addition 
of blank dextran to free cofactors changed the rates 
less than 10%. Another factor that would be especially 
pronounced for Sepharose-NAD’, is the trapping of 
enzyme molecules in complexes with preferentially 
reduced polymer-bound nucleotides. Such complexes 
could have a considerable ife-time in the absence of 
interacting free nucleotides, and would thus lower the 
121 
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Free and polymer-bound nicotinamide nucleotides as cofactors to alcohol dehydrogenase and lactate dehydrogenase 
Cofactor Reduction rate Oxidation rate Cycling rate 
with ADH with LDH with ADH + LDH 
bM/min) W) @M/min) (%) &M/mm) (cycles/hr) (%) 
NAD (H) 28 100 16 100 69 41 100 
NAD(H) + blank dextran 29 104 15 9s _ _ _ 
N6 -R-NAD(H) 17 61 12 76 42 25 61 
N6-R-NAD(H) blank dextran 16 57 11 70 _ _ _ 
dextran-NAD(H) 4.3 16 2.3 14 12 7.4 18 
Sepharose-NAD(H) 0.2 0.7 0.02 0.1 0.3 0.2 0.5 
The cofactor reduction and oxidation rates were determined at 340 nm with yeast ADH (0.30 ccg/ml) or with rabbit muscle LDH 
(0.06 ng/ml). The cycling experiment was carried out with a lo-fold higher concentration of both enzymes, and the cycling rates 
are expressed as the initial rates of formation of lactate (derived from fig. 2) or as the number of redox cycles of the cofactor per 
hour. All rates are also given relative to free NAD(H) (NAD(H) = 100%). Further details are given in Methods. N6-R-NAD(H) = 
NAD(H)-N6-[N-(6-aminohexyl)-acetamide] . 
concentration of the catalytically operational enzyme. Acknowledgements 
The data in table 1 and the curves in fig. 2 clearly 
show that dextran-NAD’ is a far more efficient co- 
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